Lysine
• L-Lysine, Lysine Hydrochloride
Lysine is an essential amino acid, one that you need to get from food. Some evidence suggests that supplemental lysine may be able to help prevent herpes infections (cold sores and genital herpes).
Requirements/Sources
Most people need about 1 g of lysine per day. The requirement may be greater for athletes and people recovering from major injuries, especially burns. The richest sources of lysine are animal proteins such as meat and poultry, but it is also found in dairy products, eggs, and beans.
Therapeutic Dosages
A typical therapeutic dosage of lysine for herpes infections is 1 g three times daily. You can take this as a regular part of your diet in hopes of preventing herpes flare-ups, or, perhaps, at the first sign of an attack. Although the evidence isn't strong, there may be some advantage to restricting your intake of foods that contain a lot of arginine, such as chocolate, peanuts, other nuts and seeds, and, to a lesser extent, wheat.
Therapeutic Uses
Some small studies suggest that regular use of lysine supplements can help prevent flareups of cold sores and genital herpes, although other studies have not found benefit. 1-6 Lysine has also been proposed as a treatment to take at the onset of a flareup, but at least one study failed to find it effective for this purpose. 7
Both cold sores and genital herpes are caused by a virus called herpes simplex . After you are first infected, this virus hides in certain nerve cells and reemerges under times of stress . Test tube research suggests that lysine fights this virus by blocking arginine , an amino acid the virus needs in order to replicate. 8 For this reason, lysine might be most effective when used in conjunction with a low-arginine diet. However, this widely stated claim has not been proven. (Note that if this is true, it would be essential to avoid taking arginine supplements if you have herpes.)
What Is the Scientific Evidence for Lysine?
When taken in sufficient doses, it appears that regular use of lysine supplements might be able to reduce the number and intensity of herpes flare-ups. 9
One double-blind, placebo-controlled study followed 52 participants with a history of herpes flare-ups. 11 While receiving 3 g of L-lysine every day for 6 months, the treatment group experienced an average of 2.4 fewer herpes flare-ups than the placebo group—a significant difference. The lysine group's flare-ups were also significantly less severe and healed faster.
Another double-blind placebo-controlled crossover study on 41 subjects also found improvements in the frequency of attacks. 12 Interestingly, this study found that 1,250 mg of lysine daily worked, but 624 mg did not.
Other studies, including one that followed 65 individuals, found no benefit, but they used lower dosages of lysine. 13,14
Although some are promising, none of these studies are large enough to give conclusive answers. At this point, more evidence is needed to determine whether lysine is effective for preventing herpes simplex.
Many people use lysine in a different way—they take it at the onset of a herpes attack. However, a double-blind, placebo-controlled study evaluating this method found no benefit. 10 (Consider using the herb lemon balm instead.)
Safety Issues
Although lysine is an essential part of the diet, the safety of concentrated lysine supplements has not been well studied. In animal studies, high dosages have caused gallstones and elevated cholesterol levels, 15,16 so you may want to use caution when using lysine if you have either of these problems. Maximum safe dosages for young children, pregnant or nursing women, or those with severe liver or kidney disease have not been established.
References
1. Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr . 1997;16:7-21.
2. Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica . 1987;175:183-190.
3. McCune MA, Perry HO, Muller SA, et al. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis . 1984;34:366-373.
4. Simon CA, Van Melle GD, Ramelet AA. Failure of lysine in frequently recurrent herpes simplex infection [letter]. Arch Dermatol . 1985;121:167-168.
5. DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol . 1984;120:48-51.
6. Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol. 1980;60:85-87.
7. Milman N, Scheibel J, Jessen O. Failure of lysine treatment in recurrent herpes simplex labialis [letter]. Lancet. 1978;2:942.
8. Griffith RS, DeLong DC, Nelson JD. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture. Chemotherapy . 1981;27:209-213.
9. Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr . 1997;16:7-21.
10. Milman N, Scheibel J, Jessen O. Failure of lysine treatment in recurrent herpes simplex labialis [letter]. Lancet. 1978;2:942.
11. Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica . 1987;175:183-190.
12. McCune MA, Perry HO, Muller SA, et al. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis . 1984;34:366-373.
13. DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol . 1984;120:48-51.
14. Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol. 1980;60:85-87.
15. Kritchevsky D, Weber MM, Klurfeld DM. Gallstone formation in hamsters: Influence of specific amino acids. Nutr Rep Int . 1984;29:117-121.
16. Leszczynski DE, Kummerow FA. Excess dietary lysine induces hypercholesterolemia in chickens. Experientia . 1982;38:266-267.
17. Griffith RS, DeLong DC, Nelson JD. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture. Chemotherapy . 1981;27:209-213.
Last reviewed April 2009 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.